Producing maternal health supplies in sub-Saharan Africa ...
Understanding the landscape to expand, strengthen, and diversify African-based manufacturing
Expanding production of active pharmaceutical ingredients (APIs) in Africa would increase the availability of essential medicines, reduce supply chain vulnerabilities, and improve health security and economic growth.
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored technologies was among the key draws at this year’s World Vaccine Congress (WVC) on April 3-6 in Washington, D.C.
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines crisis: the Nitrosamines Analytical Hub, a public, web-based repository of downloadable analytical procedures to test for nitrosamine impurities and related substances in pharmaceuticals.